Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2002
06/27/2002WO2001087938A3 Polynucleotide sequence encoding a putative cell adhesion molecule
06/27/2002WO2001085215A3 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS
06/27/2002WO2001083746A3 Regulatory nucleic acid sequences of the abc1 gene
06/27/2002WO2001079227A3 Haplotypes of the pi4 gene
06/27/2002WO2001077375A3 Diagnosis of diseases associated with gene regulation
06/27/2002WO2001073091A3 Methods of selection and development of plants having improved root quality and root lodging resistance
06/27/2002WO2001072994A3 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
06/27/2002WO2001072293A3 Antiprogestins with partial agonist activity
06/27/2002WO2001070978A3 Polypeptides and nucleic acids encoding same
06/27/2002WO2001057518A3 Method of non-targeted complex sample analysis
06/27/2002WO2001057245A3 Hiv-1 resistance assay
06/27/2002WO2001051672A3 System and method for controlling male fertility
06/27/2002WO2001046463A3 Methods for the preparation and use of internal standards for nucleic acid amplification assays
06/27/2002WO2001044816B1 Conformational and topological protein regulation
06/27/2002WO2001031056A3 Detection method by pcr
06/27/2002WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
06/27/2002WO2001006249B1 Organic semiconductor recognition complex and system
06/27/2002WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics
06/27/2002WO2000063437A9 Detection of nucleic acid reactions on bead arrays
06/27/2002WO2000061819A9 Methods of detection and modulation of age-related mutations
06/27/2002US20020083488 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences
06/27/2002US20020083482 Method for breeding disease resistant domesticated fowl
06/27/2002US20020083481 Vectors and methods for the mutagenesis of mammalian genes
06/27/2002US20020083479 Insertion of nucleotide sequences into genome of germ cells; obtain gonads, incubate with transfection mixture, allow insertion, monitor cells for preferential marker
06/27/2002US20020082540 Surgical drapes that incorporate a fluid control film; wound dressings
06/27/2002US20020082413 PGC-1, a novel brown fat PPARgamma coactivator
06/27/2002US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa
06/27/2002US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections
06/27/2002US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto
06/27/2002US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders
06/27/2002US20020082385 Protein for use in dietetics and the treatment of diabebtes
06/27/2002US20020082235 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
06/27/2002US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses
06/27/2002US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds
06/27/2002US20020082227 An ester linkage moieties of the oligonucleotide is replaced with a thioate linkage, such as phosphrothioates, useful as therapies for treating abnormal/undesirable conditions which can arise as a result of complement activation
06/27/2002US20020082216 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
06/27/2002US20020082211 Human presenilin variant
06/27/2002US20020082205 Human FGF-23 gene and gene expression products
06/27/2002US20020082194 Drug-metabolizing proteins that are related to the UDP-glucuronosyltransferase drug-metabolizing enzyme subfamily, recombinant DNA molecules and protein production
06/27/2002US20020082192 Contacting cell with compound that activates extracellular signal regulated kinase, p42/44MAPK, wherein activation of kinase results in induction of low density lipoprotein receptor expression; treatment of hypercholesterolemia
06/27/2002US20020082191 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders
06/27/2002US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders
06/27/2002US20020081751 Spheres; for use in the color separation
06/27/2002US20020081744 Methods and apparatuses for characterization of single polymers
06/27/2002US20020081724 Culture of stem cells; for use in human therapeutics
06/27/2002US20020081720 Receptor activator of NF-kappaB
06/27/2002US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds
06/27/2002US20020081716 Semiconductor element and device for detecting organic molecules and method for measuring organic molecules using same
06/27/2002US20020081715 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support
06/27/2002US20020081714 Devices and methods to form a randomly ordered array of magnetic beads and uses thereof
06/27/2002US20020081708 Novel chimeric promoters
06/27/2002US20020081702 Enzymatic polypetide for use in treatment of textiles, papermaking and animal feeds
06/27/2002US20020081693 Plant caffeoyl-coa o-methyltransferase
06/27/2002US20020081691 Delta 1-pyrroline-5-carboxylate reductase homolog
06/27/2002US20020081690 Hybrid enzyme and use thereof
06/27/2002US20020081688 Retinoid pathway assays, and compositions therefrom
06/27/2002US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders
06/27/2002US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections
06/27/2002US20020081681 Nucleotide sequences coding enzymatic polypeptides for use in the treatment of kidney disorders
06/27/2002US20020081666 Preferentially cleaving nucleotide sequences, obtain nucleotide sequences, incubate with enzymatic polypeptide, recover nucleotide sequences
06/27/2002US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents
06/27/2002US20020081659 Nucleic acids, proteins and antibodies
06/27/2002US20020081657 21784, a novel human calcium channel family member and uses thereof
06/27/2002US20020081656 UDP-N-acetylglucosamine: Galactose-beta1,3-N-acetylgalactosamine-alpha-R / N-acetylglucosamine-beta1,3,-N-acetylgalactosamine-alpha-R (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2/4GnT
06/27/2002US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/27/2002US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent
06/27/2002US20020081648 Peptide for use in human thereapeutics and diagnostics
06/27/2002US20020081645 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control
06/27/2002US20020081641 Detection of tissue modelling defects; obtain tissue sample, monitor sample for preferential enzymatic complex, compare pattern of enzyme activity with control
06/27/2002US20020081640 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
06/27/2002US20020081638 Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
06/27/2002US20020081637 Screening mammalian sample for cancer cells; obtain tissue sample, monitor sample for the expression of endothelial growth factor, the presence of enothelial growth factor exression is indicative of cancer
06/27/2002US20020081634 Detecting preferential enzyme inhibitors; obtain sample containing protease, incubate with amyloid precursor protein, incubate with modulators, compare amount of amyloid precursor protein processing with control
06/27/2002US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
06/27/2002US20020081630 Compound for use in the deteCtion of viral infectionS
06/27/2002US20020081628 Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
06/27/2002US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states
06/27/2002US20020081622 Nucleotide sequences which code polypeptide for use in the treatment and prevention of bacterial infection
06/27/2002US20020081621 Detecting preferential ligand in sample; obtain target in sample, incubate with reactive support, detect bound particles
06/27/2002US20020081620 Probes for variance detection
06/27/2002US20020081619 Separation of preferential nucleotide sequences; obtain sample, incubate with solid support, elute, recover preferential nucleotide sequences
06/27/2002US20020081618 Sampling and storage system for genetic mateiral from tissue
06/27/2002US20020081616 4,7-dichlorofluorescein dyes as molecular probes
06/27/2002US20020081615 Detecting preferential microorganism in sample; obtain sample, incubate with primers, amplify nucleotide sequences, detect microorganism by comparison of sequence products to control
06/27/2002US20020081614 Functional genomics using zinc finger proteins
06/27/2002US20020081613 Detecting cancer in a tissue sample; obtain tissue sample, screen for preferential marker, presence of marker indicates cancer
06/27/2002US20020081612 Detection and diagnosis of smoking related cancers
06/27/2002US20020081611 Kit for use in the detection and diagnosis of cancer in humans
06/27/2002US20020081610 Assays and materials for embryonic gene expression
06/27/2002US20020081608 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of cancer
06/27/2002US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies
06/27/2002US20020081606 Methods for detecting and identifying a gram positive bacteria in a sample
06/27/2002US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses
06/27/2002US20020081603 Isolating preferential polynucleotide sequences from library; obtain cellular chromatin, incubate with probe, fragment nucleotide sequences, recover marked polynucleotides
06/27/2002US20020081602 Detecting modulator of weight control; obtain cells, incubate with modulator, monitor cell resonse to modulator, compare to control
06/27/2002US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
06/27/2002US20020081600 Novel human kinase proteins and polynucleotides encoding the same
06/27/2002US20020081598 Haplotyping method for multiple distal nucleotide polymorphisms
06/27/2002US20020081597 Compositions and methods for detecting and quantifying gene expression
06/27/2002US20020081596 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers